Association of IL-1β rs16944 polymorphisms and the subsequent level of IL-1β in type 2 diabetes mellitus: Case-control study.

Strong relationships exist between immune factors and hyperglycemia, particularly proinflammatory factors such as interleukin (IL)-1β protein levels and genetics, which significantly correlate with the development of type 2 diabetes mellitus (T2DM). Exposure of pancreatic cells to IL-1β for an extended period enhances β-cell apoptosis, thereby affecting glucose metabolism. The study objective is to assess the functional role of IL-1β protein levels and the IL-1β rs16944 gene polymorphism in T2DM. A case-control study was conducted, involving 86 participants with T2DM and 74 controls. Blood samples were collected from the participants to assess their IL-β1 levels, fasting blood sugar levels, and fasting insulin levels. IL-1β (rs16944) was analyzed using conventional polymerase chain reaction. IL-1β rs16944 variations in the control group showed 32 (43%) of AA, 27 (36%) of AG, and 15 (20%) of GG, while T2DM patients showed 30 (35%) of AA, 34 (40%) of AG and 22 (26%) of GG variation. The logistic regression analysis showed a non-significant association between each variation and T2DM. The genome variation in patients with insulin resistance (IR) and T2DM was 8 (33%) AA, 6 (25%) AG, and 10 (42%) GG. The logistic regression test showed a non-significant association between each variation and patients with IR and T2DM. In conclusion, IL-1β levels and genetic variations of the IL-1β rs16944 gene do not affect blood sugar metabolism and I nsulin resistance in Iraqi diabetic patients.
Diabetes
Diabetes type 2
Access
Care/Management
Advocacy

Authors

Khdaer Khdaer, Aldabagh Aldabagh, Abdulrazzaq Abdulrazzaq, Altai Altai, Issa Issa, Jabir Jabir, Najm Najm, Hasan Hasan, Jawad Jawad, Fawzi Fawzi, Jasim Jasim, Swelum Swelum
View on Pubmed
Share
Facebook
X (Twitter)
Bluesky
Linkedin
Copy to clipboard